Compounds > 6-ethyl-3-(1h-tetrazol-5-yl)chromone
Page last updated: 2024-09-05

6-ethyl-3-(1h-tetrazol-5-yl)chromone and nivimedone

6-ethyl-3-(1h-tetrazol-5-yl)chromone has been researched along with nivimedone in 1 studies

Compound Research Comparison

Studies
(6-ethyl-3-(1h-tetrazol-5-yl)chromone)		Trials
(6-ethyl-3-(1h-tetrazol-5-yl)chromone)		Recent Studies (post-2010)
(6-ethyl-3-(1h-tetrazol-5-yl)chromone)		Studies
(nivimedone)		Trials
(nivimedone)		Recent Studies (post-2010) (nivimedone)
10001120

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Althuis, TH; Hess, HJ; Moore, PF1

Other Studies

1 other study(ies) available for 6-ethyl-3-(1h-tetrazol-5-yl)chromone and nivimedone

ArticleYear
Development of ethyl 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylate, a new prototype with oral antiallergy activity.
    Journal of medicinal chemistry, 1979, Volume: 22, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Cromolyn Sodium; Histamine Antagonists; Male; Passive Cutaneous Anaphylaxis; Pyridines; Quinolinic Acids; Rats; Structure-Activity Relationship

1979